Jacob Hughes
Stock Analyst at Wells Fargo
(1.32)
# 3,514
Out of 4,915 analysts
27
Total ratings
50%
Success rate
-1.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $20.95 | +110.02% | 5 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $26.67 | +102.47% | 1 | Sep 6, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $0.76 | +1,601.57% | 3 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $18.64 | +200.43% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $5.88 | +546.26% | 3 | May 4, 2022 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Equal-Weight | $12 → $11 | $15.45 | -28.80% | 11 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $5.89 | +188.62% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $20.95
Upside: +110.02%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $26.67
Upside: +102.47%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $0.76
Upside: +1,601.57%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $18.64
Upside: +200.43%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $5.88
Upside: +546.26%
Teva Pharmaceutical Industries
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $15.45
Upside: -28.80%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $5.89
Upside: +188.62%